Olivia
Online
Duke Cancer Network
@DukeCancerNETWK
The Duke Cancer Network has expertise in building value-based programs that define best practices and enhance quality to best serve the needs of your community.
United States
Joined July 2016
44 Following
319 Followers
198 Posts
After NACT, patients who presented with cN1 disease should still receive ALND if residual disease found in LNs, but if they have pCR, their survival=cN0 pts’. Some pearls from @DrLolaFayanju on surgical management of breast cancer @DukeCancer review. #bcsm #DCR2019
Dr. Blitzblau also notes there is accumulation evidence for once weekly and one week courses of radiation therapy for breast cancer as well as more data on safety of hypofractionated nodal treatment #DCR2019
...BUT, Dr. Blitzblau also notes that other schedules are available for individual pts - elderly, limited transportation, etc #DCR2019
Dr Blitzblau @ #DCR2019: ASTRO 2018 Consensus statement of HF-WBRT expanded indications: PREFERRED dose fractionation scheme is HFWBI to dose of 4000 cGY in 15 fractions or 4250 cGY in 16 fractions for women w/ invasive br ca receiving WBI w/wo inclusion of low axilla....
Who to follow
Duke Cancer
@DukeCancer
Cancer creates its own rules. We recognized ending cancer requires a weapon as adaptable & multiform as the disease itself—Duke Cancer Institute.
Andrew Armstrong
@AarmstrongDuke
Professor of Medicine, Surgery, Pharmacology and Cancer Biology, Duke Cancer Institute, Durham NC
Duke Otolaryngology - HNS&CS
@Duke_Oto
Duke Department of Head and Neck Surgery & Communication Sciences, Duke University Medical Center, Durham, NC USA
Dr Sarah Sammons notes top recent wins in breast cancer: 4. OS benefit for pre/perimenopausal women with ribociclib + endocrine Rx in 1st line ER+/HER2- advanced disease #DCR2019
Dr Sarah Sammons notes top recent wins in breast cancer: 3. T-DM1 in early stage HER2+ breast cancer with residual disease post Neoadj chemo #DCR2019
Dr Sarah Sammons notes top recent wins in breast cancer: 2. Alpelisib (with Fulvestrant) approved for advanced PIK3CA mutant ER+/HER2- disease #DCR2019
Dr Sarah Sammons notes top recent wins in breast cancer: 1. First immunotherapy combination approved for first-line treatment in advanced PDL-1+ TNBC with OS benefit #DCR2019
Dr Sarah Sammons notes that AI + Ovarian suppression and CDK4/6 inhibitor (ribociclib) should be 1st line SOC in pre/perimenopausal ER+/HER2- Advanced Br Ca #DCR2019
Hepatic artery infusion: may double survival for unresectable pts & convert unresectable pts to resectable; adjuvant HAI can result in 10yr survival rates >60% #DCR2019
Dr. Lidsky advises that resection of CRLM in the setting of compromised livers (steatosis, cirrhosis, etc) require large volume/function remnants. Strategies to assist include: parenchymal preservation; ablation/resection; 2 stage resections; portal vein embolization #DCR2019
Dr Michael Lidsky summarizes KEY DEFINITION of unresectable colorectal liver mets: R0 resection would require removal of all 3 hepatic veins, both portal veins, or retrohepatic IVC and/or leave <2 adequately perfused/drained hepatic segments #DCR2019
@ndevitomd: “In resected pancreatic cancer, adjuvant mFOLFIRINOX should be considered the standard of care when patients are able to tolerate this regimen #DCR2019
To avoid nontherapeutic laparotomy, the determination of resectability of pancreatic cancer demands appropriate pre-op assessments with high quality imaging and interpretation essential, according to Dr Allen. Should consider staging laparoscopy and peritoneal cytology #DCR2019
Duke Surgical Oncologist, Peter Allen notes that given the lack of high level (randomized) data to guide options, the treatment plan for pancreatic cancer should be tailored to individual patient and tumor characteristics #DCR2019
@arifkamalmd : Patients who enter hospice describe the transition as “falling off a cliff”... You do not have to let that happen; you CAN continue to see your patients who are on hospice. @DukeCancer @DukePallCare #DCR2019
Wonder how to have empathic conversations w/ pts? Try NURSE: name (the emotion), understand, respect, support, explore. @DukePallCare #DCR2019
Trends for you
Something went wrong.